Last updated on March 2018

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Brief description of study

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Clinical Study Identifier: NCT03249376

Contact Investigators or Research Sites near you

Start Over

Kimberly Vanover, PhD

Clinical Site
Shreveport, LA United States
  Connect »